Literature DB >> 23845439

Platelets and tumor cells: a new form of border control.

Ben Z Stanger1, Mark L Kahn.   

Abstract

Tumor metastasis is the primary cause of death due to cancer, but the mechanisms by which tumor cells metastasize remain incompletely understood. In this issue of Cancer Cell, Schumacher and colleagues suggest that ATP released from tumor-associated platelets in the blood facilitates tumor metastasis by relaxing endothelial barrier function.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23845439      PMCID： PMC3743536          DOI： 10.1016/j.ccr.2013.06.009

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  8 in total

1.  Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells.

Authors:  Joseph S Palumbo; Kathryn E Talmage; Jessica V Massari; Christine M La Jeunesse; Matthew J Flick; Keith W Kombrinck; Markéta Jirousková; Jay L Degen
Journal:  Blood       Date:  2004-09-14       Impact factor: 22.113

Review 2.  AACR centennial series: the biology of cancer metastasis: historical perspective.

Authors:  James E Talmadge; Isaiah J Fidler
Journal:  Cancer Res       Date:  2010-07-07       Impact factor: 12.701

3.  Antimetastatic effects associated with platelet reduction.

Authors:  G J Gasic; T B Gasic; C C Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  1968-09       Impact factor: 11.205

4.  Lysis of tumor cells by natural killer cells in mice is impeded by platelets.

Authors:  B Nieswandt; M Hafner; B Echtenacher; D N Männel
Journal:  Cancer Res       Date:  1999-03-15       Impact factor: 12.701

Review 5.  Deadly allies: the fatal interplay between platelets and metastasizing cancer cells.

Authors:  Luise Erpenbeck; Michael P Schön
Journal:  Blood       Date:  2010-03-01       Impact factor: 22.113

6.  Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas.

Authors:  Mark Wahrenbrock; Lubor Borsig; Dzung Le; Nissi Varki; Ajit Varki
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

7.  Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis.

Authors:  Eric Camerer; Aisha A Qazi; Daniel N Duong; Ivo Cornelissen; Rommel Advincula; Shaun R Coughlin
Journal:  Blood       Date:  2004-03-18       Impact factor: 22.113

8.  Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis.

Authors:  Myriam Labelle; Shahinoor Begum; Richard O Hynes
Journal:  Cancer Cell       Date:  2011-11-15       Impact factor: 31.743
  8 in total
  19 in total

1.  [Clinical features and prognosis of children with acute lymphoblastic leukemia and different platelet levels].

Authors:  Ao-Li Zhang; Xiao-Juan Chen; Yao Zou; Wen-Yu Yang; Ye Guo; Shu-Chun Wang; Li Zhang; Xiao-Ming Liu; Min Ruan; Tian-Feng Liu; Ben-Quan Qi; Xiao-Fan Zhu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2019-08

2.  A novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinoma.

Authors:  Lu Wang; Cong Wang; Jiangfeng Wang; Xiaochen Huang; Yufeng Cheng
Journal:  J Cancer Res Clin Oncol       Date:  2017-06-10       Impact factor: 4.553

Review 3.  Emerging molecular basis of hematogenous metastasis in gastric cancer.

Authors:  Jing Zhong; Yan Chen; Liang-Jing Wang
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

4.  Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma.

Authors:  Bernhard Scheiner; Martha Kirstein; Sabine Popp; Florian Hucke; Simona Bota; Nataliya Rohr-Udilova; Thomas Reiberger; Christian Müller; Michael Trauner; Markus Peck-Radosavljevic; Arndt Vogel; Wolfgang Sieghart; Matthias Pinter
Journal:  Liver Cancer       Date:  2018-06-22       Impact factor: 11.740

Review 5.  Platelets and extracellular vesicles and their cross talk with cancer.

Authors:  Sophia Lazar; Lawrence E Goldfinger
Journal:  Blood       Date:  2021-06-10       Impact factor: 22.113

6.  Preoperative Systemic Immune-Inflammation Index (SII) for Predicting the Survival of Patients with Stage I-III Gastric Cancer with a Signet-Ring Cell (SRC) Component.

Authors:  Ziyu Zhu; Xiliang Cong; Rui Li; Xin Yin; Chunfeng Li; Yingwei Xue
Journal:  Biomed Res Int       Date:  2020-05-22       Impact factor: 3.411

Review 7.  Molecular alterations of cancer cell and tumour microenvironment in metastatic gastric cancer.

Authors:  Weilin Li; Jennifer Mun-Kar Ng; Chi Chun Wong; Enders Kwok Wai Ng; Jun Yu
Journal:  Oncogene       Date:  2018-05-23       Impact factor: 9.867

8.  Systemic immune-inflammation index, thymidine phosphorylase and survival of localized gastric cancer patients after curative resection.

Authors:  Liu Huang; Shan Liu; Yu Lei; Kun Wang; Min Xu; Yaobing Chen; Bo Liu; Yangyang Chen; Qiang Fu; Peng Zhang; Kai Qin; Yixin Cai; Shengling Fu; Shuwang Ge; Xianglin Yuan
Journal:  Oncotarget       Date:  2016-07-12

Review 9.  Platelet-inspired medicine for tumor therapy.

Authors:  Jie Yang; Shujun Wang; Ping Liu; Lu Dai; Baoan Chen; Jianfeng Luan; Jiaying Zhou
Journal:  Oncotarget       Date:  2017-12-01

10.  Unfractionated and Low Molecular Weight Heparin Reduce Platelet Induced Epithelial-Mesenchymal Transition in Pancreatic and Prostate Cancer Cells.

Authors:  Jan Moritz Ponert; Lukas Maria Gockel; Svenja Henze; Martin Schlesinger
Journal:  Molecules       Date:  2018-10-19       Impact factor: 4.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.